These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6239618)

  • 1. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
    Micklem KJ; Sim RB; Sim E
    Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    Iida K; Nadler L; Nussenzweig V
    J Exp Med; 1983 Oct; 158(4):1021-33. PubMed ID: 6225820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
    Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
    J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
    Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
    J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement fragment C3d facilitates phagocytosis by monocytes.
    Gaither TA; Vargas I; Inada S; Frank MM
    Immunology; 1987 Nov; 62(3):405-11. PubMed ID: 3499379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
    Weis JJ; Richards SA; Smith JA; Fearon DT
    J Immunol Methods; 1986 Aug; 92(1):79-87. PubMed ID: 3018085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
    Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
    Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3).
    Malhotra V; Hogg N; Sim RB
    Eur J Immunol; 1986 Sep; 16(9):1117-23. PubMed ID: 3530784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.
    Kubota Y; Gaither TA; Cason J; O'Shea JJ; Lawley TJ
    J Immunol; 1987 Feb; 138(4):1137-42. PubMed ID: 3027170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.
    Bartók I; Walport MJ
    J Immunol; 1995 May; 154(10):5367-75. PubMed ID: 7730637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells.
    Rask R; Rasmussen JM; Jepsen HH; Svehag SE
    APMIS; 1989 Apr; 97(4):374-80. PubMed ID: 2524204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of C3d receptors on Candida albicans.
    Calderone RA; Linehan L; Wadsworth E; Sandberg AL
    Infect Immun; 1988 Jan; 56(1):252-8. PubMed ID: 2961702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.